Immune response in mice and swine to DNA vaccines derived from the Pasteurella multocida toxin gene

Vaccine

Volumn 25, Issue 32, 2007, Pages 6118-6128

  Register, Karen B ^a   Sacco, Randy E ^a   Brockmeier, Susan L ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

DNA vaccine; Pasteurella multocida; Toxin

Indexed keywords

BACTERIAL TOXIN; DNA VACCINE; GAMMA INTERFERON; PLASMID VECTOR; RECOMBINANT ANTIBODY; TOXIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; ATROPHIC RHINITIS; BACTERIAL STRAIN; CELL SECRETION; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA PURIFICATION; DNA SEQUENCE; FEMALE; GRAM NEGATIVE INFECTION; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PASTEURELLA MULTOCIDA; PRIORITY JOURNAL; SPLEEN CELL; STATISTICAL SIGNIFICANCE; SWINE;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BACTERIAL VACCINES; BORDETELLA BRONCHISEPTICA; BORDETELLA INFECTIONS; DNA, BACTERIAL; MICE; MOLECULAR SEQUENCE DATA; NOSE; PASTEURELLA INFECTIONS; PASTEURELLA MULTOCIDA; SWINE; VACCINES, DNA;

EID: 34447531820     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.05.028     Document Type: Article

References (32)

1. de Jong M.F. Progressive and nonprogressive atrophic rhinitis. In: Straw B.E., Zimmerman J.J., d'Allaire S., and Taylor D.J. (Eds). Diseases of swine (2006), Blackwell Publishing, Ames, IA 577-602
2. Foged N.T. Pasteurella multocida toxin. The characterisation of the toxin and its significance in the diagnosis and prevention of progressive atrophic rhinitis in pigs. APMIS 100 Suppl. 25 (1992) 1-56
3. Busch C., Orth J., Djouder N., and Aktories K. Biological activity of a C-terminal fragment of Pasteurella multocida toxin. Infect Immun 69 6 (2001) 3628-3634
4. Pullinger G.D., Sowdhamini R., and Lax A.J. Localization of functional domains of the mitogenic toxin of Pasteurella multocida. Infect Immun 69 12 (2001) 7839-7850
5. Ward P.N., Miles A.J., Sumner I.G., Thomas L.H., and Lax A.J. Activity of the mitogenic Pasteurella multocida toxin requires an essential C-terminal residue. Infect Immun 66 12 (1998) 5636-5642
6. Nielsen J.P., Foged N.T., Sorensen V., Barfod K., Bording A., and Petersen S.K. Vaccination against progressive atrophic rhinitis with a recombinant Pasteurella multocida toxin derivative. Can J Vet Res 55 2 (1991) 128-138
7. Petersen S.K., Foged N.T., Bording A., Nielsen J.P., Riemann H.K., and Frandsen P.L. Recombinant derivatives of Pasteurella multocida toxin: candidates for a vaccine against progressive atrophic rhinitis. Infect Immun 59 4 (1991) 1387-1393
8. Liao C.M., Huang C., Hsuan S.L., Chen Z.W., Lee W.C., Liu C.I., et al. Immunogenicity and efficacy of three recombinant subunit Pasteurella multocida toxin vaccines against progressive atrophic rhinitis in pigs. Vaccine 24 1 (2006) 27-35
9. To H., Someno S., and Nagai S. Development of a genetically modified nontoxigenic Pasteurella multocida toxin as a candidate for use in vaccines against progressive atrophic rhinitis in pigs. Am J Vet Res 66 1 (2005) 113-118
10. Dunham S.P. The application of nucleic acid vaccines in veterinary medicine. Res Vet Sci 73 1 (2002) 9-16
11. Rogan D., and Babiuk L.A. Novel vaccines from biotechnology. Rev Sci Tech 24 1 (2005) 159-174
12. Luke C.J., Carner K., Liang X., and Barbour A.G. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. J Infect Dis 175 1 (1997) 91-97
13. Rimler R.B., and Brogden K.A. Pasteurella multocida isolated from rabbits and swine: serologic types and toxin production. Am J Vet Res 47 4 (1986) 730-737
14. Sharp P.M., and Li W.H. The codon adaptation index-a measure of directional synonymous codon usage bias, and its potential applications. Nucleic Acids Res 15 3 (1987) 1281-1295
15. Brockmeier S.L., Register K.B., Magyar T., Lax A.J., Pullinger G.D., and Kunkle R.A. Role of the dermonecrotic toxin of Bordetella bronchiseptica in the pathogenesis of respiratory disease in swine. Infect Immun 70 2 (2002) 481-490
16. Williams P.P., Hall M.R., and Rimler R.B. Host response to Pasteurella multocida turbinate atrophy toxin in swine. Can J Vet Res 54 1 (1990) 157-163
17. Sacco R.E., Jensen R.J., Thoen C.O., Sandor M., Weinstock J., Lynch R.G., et al. Cytokine secretion and adhesion molecule expression by granuloma T lymphocytes in Mycobacterium avium infection. Am J Pathol 148 6 (1996) 1935-1948
18. Hempel D.M., Smith K.A., Claussen K.A., and Perricone M.A. Analysis of cellular immune responses in the peripheral blood of mice using real-time RT-PCR. J Immunol Methods 259 1-2 (2002) 129-138
19. Overbergh L., Giulietti A., Valckx D., Decallonne R., Bouillon R., and Mathieu C. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14 1 (2003) 33-43
20. Waters W.R., Pesch B.A., Hontecillas R., Sacco R.E., Zuckermann F.A., and Wannemuehler M.J. Cellular immune responses of pigs induced by vaccination with either a whole cell sonicate or pepsin-digested Brachyspira (Serpulina) hyodysenteriae bacterin. Vaccine 18 7-8 (1999) 711-719
21. - Δ Δ CT method. Methods 25 4 (2001) 402-408
22. Miller J., Jenny A., Rhyan J., Saari D., and Suarez D. Detection of Mycobacterium bovis in formalin-fixed, paraffin-embedded tissues of cattle and elk by PCR amplification of an IS6110 sequence specific for Mycobacterium tuberculosis complex organisms. J Vet Diagn Invest 9 3 (1997) 244-249
23. Register K.B., and DeJong K.D. Analytical verification of a multiplex PCR for identification of Bordetella bronchiseptica and Pasteurella multocida from swine. Vet Microbiol 117 2-4 (2006) 201-210
24. Anonymous. Porcine progressive atrophic rhinitis vaccine (inactivated). European Pharmacopoeia (Suppl). 3rd ed. (1999), Council of Europe, Strasbourg p. 788-90
25. Petersen S.K. The complete nucleotide sequence of the Pasteurella multocida toxin gene and evidence for a transcriptional repressor TxaR. Mol Microbiol 4 5 (1990) 821-830
26. Bording A., Nymark K., and Smidt E. Field trials with a new genetically engineered vaccine for protection against progressive atrophic rhinitis in pigs. Acta Vet Scand 35 2 (1994) 155-163
27. Riising H.J., van Empel P., and Witvliet M. Protection of piglets against atrophic rhinitis by vaccinating the sow with a vaccine against Pasteurella multocida and Bordetella bronchiseptica. Vet Rec 150 18 (2002) 569-571
28. Sorensen V., Barfod K., Nielsen J.P., and Foged N.T. Effect of degree of atrophy and serum antitoxin titer on the daily weight gain and feed conversion. Proceedings of the 11th International Pig Veterinary Society Congress (1990) 57
29. de Jong M.F., Schaake Jr. J., and Borst G.H.A. Neutralization test against AR-toxin of Pasteurella multocida in pig herds after vaccination with AR-vaccines. Proceedings of the 9th International Pig Veterinary Society Congress (1986) 221
30. Frymus T., Müller E., Schulte A., Kobatsch B., Ueberschär S., and Petzoldt K. Studies in conventional and gnotobiotic piglets on the pathogenicity and immunogenicity of a toxin from Pasteurella multocida involved in atrophic rhinitis. Proceedings of the 9th International Pig Veterinary Society Congress (1986) 229
31. van Diemen P.M., de Jong M.F., de Vries Reilingh G., van der Hel P., and Schrama J.W. Intranasal administration of Pasteurella multocida toxin in a challenge-exposure model used to induce subclinical signs of atrophic rhinitis in pigs. Am J Vet Res 55 1 (1994) 49-54
32. van Diemen P.M., de Vries Reilingh G., and Parmentier H.K. Immune responses of piglets to Pasteurella multocida toxin and toxoid. Vet Immunol Immunopathol 41 3-4 (1994) 307-321